For preterm infants, there is no universal Lactobacillus dose. It must match the specific strain and NICU product protocol.
A commonly cited regimen for NEC prevention is:
- Lactobacillus rhamnosus GG (ATCC 53103): 1 × 10⁹ to 6 × 10⁹ CFU once daily enterally
Some protocols instead use a multi-strain product, commonly at about 10⁹ total CFU/day, rather than Lactobacillus alone.
Do not substitute an over-the-counter Lactobacillus product or estimate drops/sachets from a CFU target. In a preterm baby, strain identity, product quality, preparation, and eligibility matter because rare probiotic sepsis has occurred. Use only the local neonatology/NICU guideline.For preterm infants, there is no universal dose for “Lactobacillus” because effects are strain-specific.
The ESPGHAN position paper conditionally recommends, only when stringent NICU safety and product-quality conditions are met:
- Lacticaseibacillus rhamnosus GG (LGG), ATCC 53103: 1 × 10⁹ to 6 × 10⁹ CFU once daily enterally for prevention of stage II or III NEC. Evidence certainty is low. ESPGHAN position paper
Do not substitute another Lactobacillus product or dose automatically. Product strain, viable CFU at administration, preparation, and local neonatal protocol matter. In extremely preterm/ELBW infants, the benefit is less certain and probiotic-associated sepsis, though rare, is a concern.
Use only under the treating neonatologist's NICU protocol, not an OTC preparation.